- Home
- SAGE vs SFIX Comparison
SAGE vs SFIX Comparison
Compare SAGE & SFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- SFIX
- Stock Information
- Founded
- SAGE 2010
- SFIX 2011
- Country
- SAGE United States
- SFIX United States
- Employees
- SAGE N/A
- SFIX N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- SFIX Catalog/Specialty Distribution
- Sector
- SAGE Health Care
- SFIX Consumer Discretionary
- Exchange
- SAGE Nasdaq
- SFIX Nasdaq
- Market Cap
- SAGE 571.1M
- SFIX 482.8M
- IPO Year
- SAGE 2014
- SFIX 2017
- Fundamental
- Price
- SAGE $9.12
- SFIX $4.62
- Analyst Decision
- SAGE Hold
- SFIX Hold
- Analyst Count
- SAGE 18
- SFIX 4
- Target Price
- SAGE $9.89
- SFIX $5.67
- AVG Volume (30 Days)
- SAGE 1.8M
- SFIX 2.0M
- Earning Date
- SAGE 07-30-2025
- SFIX 06-10-2025
- Dividend Yield
- SAGE N/A
- SFIX N/A
- EPS Growth
- SAGE N/A
- SFIX N/A
- EPS
- SAGE N/A
- SFIX N/A
- Revenue
- SAGE $47,404,000.00
- SFIX $1,275,494,000.00
- Revenue This Year
- SAGE $101.71
- SFIX N/A
- Revenue Next Year
- SAGE $42.30
- SFIX N/A
- P/E Ratio
- SAGE N/A
- SFIX N/A
- Revenue Growth
- SAGE N/A
- SFIX N/A
- 52 Week Low
- SAGE $4.62
- SFIX $2.21
- 52 Week High
- SAGE $13.47
- SFIX $6.99
- Technical
- Relative Strength Index (RSI)
- SAGE 66.62
- SFIX 66.38
- Support Level
- SAGE $9.10
- SFIX $4.03
- Resistance Level
- SAGE $9.36
- SFIX $4.56
- Average True Range (ATR)
- SAGE 0.10
- SFIX 0.22
- MACD
- SAGE -0.09
- SFIX 0.07
- Stochastic Oscillator
- SAGE 29.69
- SFIX 97.27
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About SFIX Stitch Fix Inc.
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.